APA (7th ed.) Citation

Garcia-Velasco, J. A., Bennink, H. J. T. C., Epifanio, R., Escudero, E., Pellicer, A., & Simón, C. (2007). High-dose recombinant LH add-back strategy using high-dose GnRH antagonist is an innovative protocol compared with standard GnRH antagonist. Reproductive BioMedicine Online (Reproductive Healthcare Limited), 15(3), 280. https://doi.org/10.1016/S1472-6483(10)60340-9

Chicago Style (17th ed.) Citation

Garcia-Velasco, J. A., H. J. T. Coelingh Bennink, R. Epifanio, E. Escudero, A. Pellicer, and C. Simón. "High-dose Recombinant LH Add-back Strategy Using High-dose GnRH Antagonist Is an Innovative Protocol Compared with Standard GnRH Antagonist." Reproductive BioMedicine Online (Reproductive Healthcare Limited) 15, no. 3 (2007): 280. https://doi.org/10.1016/S1472-6483(10)60340-9.

MLA (9th ed.) Citation

Garcia-Velasco, J. A., et al. "High-dose Recombinant LH Add-back Strategy Using High-dose GnRH Antagonist Is an Innovative Protocol Compared with Standard GnRH Antagonist." Reproductive BioMedicine Online (Reproductive Healthcare Limited), vol. 15, no. 3, 2007, p. 280, https://doi.org/10.1016/S1472-6483(10)60340-9.